| Ex-vivo Hypotermic Perfusion in Patients With Hepatocellular Carcinoma to Reduce the Incidence of Tumor Recurrence (NCT06720675) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2022-06-03 |
| Liver Transplantation for Unresectable GIST Liver Metastases (NCT04825470) | Hospital Universitario Virgen de la Arrixaca | 2022-05-01 |
| Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device (NCT06789224) | Lindis Bloodcare GmbH | 2022-02-15 |
| Radiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic Cancers (NCT04682847) | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | 2020-11-19 |
| Durvalumab and Lenvatinib in Participants With Locally Advanced and Metastatic Hepatocellular Carcinoma ( Dulect2020-1 ) (NCT04443322) | RenJi Hospital | 2020-09-19 |
| Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis (NCT04288323) | University of California, San Diego | 2018-04-27 |
| AFP Model and Liver Transplantation. (NCT03775863) | Austral University, Argentina | 2017-11-11 |
| Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery (NCT04955808) | National Cancer Institute (NCI) | 2017-02-07 |
| Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) (NCT02465060) | National Cancer Institute (NCI) | 2015-08-17 |
| Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation (NCT02424955) | Stanford University | 2014-11-18 |
| CIRSE Registry for SIR-Spheres Therapy (NCT02305459) | Cardiovascular and Interventional Radiological Society of Europe | 2014-11-01 |
| Analysis of Body Composition in Patients With Hepatocellular Carcinoma in Radioablation (NCT01744639) | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 2012-12-01 |
| SorAfenib Versus RADIOEMBOLIZATION in Advanced Hepatocellular Carcinoma (NCT01482442) | Assistance Publique - Hôpitaux de Paris | 2011-12-01 |
| The Illness of Uncertainty, Personality and Coping Strategies in Patients With Hepatocellular Carcinoma (NCT01380392) | National Taiwan University Hospital | 2011-02-01 |
| Sorafenib Plus Doxorubicin Versus Sorafenib Alone for the Treatment of Advanced Hepatocellular Carcinoma: a Randomized Phase II Trial (NCT01272557) | PD Dr. med. Matthias Dollinger | 2010-12-01 |
| Combination SBRT With TACE for Unresectable Hepatocellular Carcinoma (NCT01020812) | Stanford University | 2009-09-01 |
| Dose Finding Study of AVE1642 in Patients With Advanced or Metastatic Liver Carcinoma (NCT00791544) | Sanofi | 2008-11-01 |
| Permission to Collect Blood Over Time for Research (NCT00767234) | Stanford University | 2008-08-01 |
| Combined HCC-MFCCC (NCT03178409) | University of Milan | 2004-01-01 |
| Hepatocellular Carcinoma Treated With Iodine-125 Implantation (NCT01717729) | The Second People's Hospital of GuangDong Province | 2000-01-01 |
| De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma (NCT00328770) | University of Alberta | 1996-12-01 |